ArticleEJHaem2022

CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment.

Audrey Abecassis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.